Novel Peptide-Based Immunotherapy Holds Promise for Peanut Allergy
PVX108, a peptide-based immunotherapy in development for the treatment of peanut allergy, demonstrated a favorable safety profile.
All articles by Britt Gambino
SABA Reduction Program Helped More Patients Achieve Ideal Asthma Medication Ratio Goal
Researchers sought to determine whether a multidisciplinary SABA reduction program would significantly increase the percentage of patients who reached an AMR ≥0.5.
Accidental Exposure to Peanut Reported Less Often With AR101 Treatment
Patients who were actively treated with AR101, an investigational oral biologic with a characterized peanut protein profile, reported accidental exposure to peanut less often, had fewer associated adverse events, and required less rescue medication compared with placebo.
Quality of Sleep in Allergic Rhinitis Improved With House Dust Mite SLIT Tablet
Quality of sleep significantly improved in patients with allergic rhinitis who were treated with the house dust mite (HDM) sublingual immunotherapy-tablet (12 SQ-HDM), according to a post hoc analysis.
